glp 1 effectiveness GLP-1 Antagonists Increase Plan Drug Spend - What's Next Dandelion Health

### Funding Statement SDL and AC were supported by the National Science Foundation (Grant Nos.\ CAREER DMS-1944574 and DMS-2325258) ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained

This review summarizes recent advances in the clinical applications of glucagon-like peptide-1 receptor agonists (GLP-1RAs) beyond their established role in glycemic control for type 2 diabetes (T2DM)

Amylin, an anorexic neuroendocrine hormone co-secreted with insulin, is deficient in individuals with diabetes and plays an important role in postprandial glucose homeostasis, with additional potential cardiovascular and neuroprotective functions

GLP-1 receptor agonists: a review of head-to-head clinical studies

If you're thinking about how to manage GLP-1 costs while improving outcomes, wed encourage you to explore the data and the broader strategy behind it

There's plenty of research happening around the world